Breast cancer is classified into molecular subtypes based on the expression levels of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and the proliferation marker Ki-67 (9, 10). This evidence concerns the gene ERBB2 and breast carcinoma.